Stock Events

Alnylam Pharmaceuticals (ALNY) Q3 2022 Earnings

28JulConfirmed
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-2.29
-2.02
-1.75
-1.48

Details

Expected EPS
-1.63
Actual EPS
-2.29
Surprise EPS
-0.66
Surprise Percent
+40.49%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.29 per share for Q3 2022.

0 Comments

Share your thoughts